Harbour BioMed Names Dr. Bob Zhang to Lead Metabolic Disease Franchise Expansion

Harbour BioMed (HKEX: 02142) has appointed physician-scientist and biotechnology executive Dr. Bob Zhang as president of its newly established Metabolic... Read More

The post Harbour BioMed Names Dr. Bob Zhang to Lead Metabolic Disease Franchise Expansion appeared first on citybiz.